PharmaResources (Shanghai) Co. Ltd. A Financial Flexibility Index
PharmaResources (Shanghai) Co. Ltd. A financial flexibility index. PharmaResources (Shanghai) Co. Ltd. A (301230) has a Financial Flexibility Index of 0.58x as of December 2025. Free cash flow of CN¥178.83 Million (operating CF CN¥135.51 Million minus capex CN¥43.32 Million) represents 1% of total liabilities (CN¥309.87 Million). See PharmaResources (Shanghai) Co. Ltd. A (301230) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Financial flexibility index of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025. Historical Financial Flexibility Index trend for PharmaResources (Shanghai) Co. Ltd. A across 6 annual periods. Check PharmaResources (Shanghai) Co. Ltd. A (301230) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
PharmaResources (Shanghai) Co. Ltd. A Financial Flexibility Index by Year (2020–2025)
PharmaResources (Shanghai) Co. Ltd. A financial flexibility index by year from 2020 to 2025. Year-by-year free cash flow to debt coverage for PharmaResources (Shanghai) Co. Ltd. A. For the full cash flow conversion analysis, see 301230 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | CN¥178.83 Million | CN¥135.51 Million | CN¥309.87 Million | ▼ -13.9% |
| 2024 | 0.67x | CN¥190.27 Million | CN¥80.86 Million | CN¥283.73 Million | ▼ -7.9% |
| 2023 | 0.73x | CN¥269.13 Million | CN¥20.86 Million | CN¥369.62 Million | ▼ -38.6% |
| 2022 | 1.19x | CN¥223.26 Million | CN¥99.29 Million | CN¥188.38 Million | ▲ +25.8% |
| 2021 | 0.94x | CN¥197.24 Million | CN¥105.12 Million | CN¥209.37 Million | ▲ +18.7% |
| 2020 | 0.79x | CN¥87.96 Million | CN¥54.45 Million | CN¥110.81 Million | — |